These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 20379969)
21. Antitumor agents. 3. Design, synthesis, and biological evaluation of new pyridoisoquinolindione and dihydrothienoquinolindione derivatives with potent cytotoxic activity. Bolognese A; Correale G; Manfra M; Lavecchia A; Mazzoni O; Novellino E; La Colla P; Sanna G; Loddo R J Med Chem; 2004 Feb; 47(4):849-58. PubMed ID: 14761187 [TBL] [Abstract][Full Text] [Related]
22. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives. Bakr RB; Mehany ABM; Abdellatif KRA Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084 [TBL] [Abstract][Full Text] [Related]
23. Anticancer and radio-sensitizing evaluation of some new thiazolopyrane and thiazolopyranopyrimidine derivatives bearing a sulfonamide moiety. Ghorab MM; Ragab FA; Heiba HI; El-Hazek RM Eur J Med Chem; 2011 Oct; 46(10):5120-6. PubMed ID: 21890248 [TBL] [Abstract][Full Text] [Related]
24. Antitumor activity of novel pyridine, thiophene and thiazole derivatives. Ghorab MM; Al-Said MS Arch Pharm Res; 2012 Jun; 35(6):965-73. PubMed ID: 22870805 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and cytotoxicity of 2-acetyl-4,8-dihydrobenzodithiophene-4, 8-dione derivatives. Chao YH; Kuo SC; Wu CH; Lee CY; Mauger A; Sun IC; Morris-Natschke SL; Lee KH J Med Chem; 1998 Nov; 41(23):4658-61. PubMed ID: 9804705 [TBL] [Abstract][Full Text] [Related]
26. Anticancer activities of some newly synthesized pyridine, pyrane, and pyrimidine derivatives. Amr AG; Mohamed AM; Mohamed SF; Abdel-Hafez NA; Hammam Ael-F Bioorg Med Chem; 2006 Aug; 14(16):5481-8. PubMed ID: 16713269 [TBL] [Abstract][Full Text] [Related]
27. Novel 6-N-arylcarboxamidopyrazolo[4,3-d]pyrimidin-7-one derivatives as potential anti-cancer agents. Devegowda VN; Kim JH; Han KC; Yang EG; Choo H; Pae AN; Nam G; Choi KI Bioorg Med Chem Lett; 2010 Mar; 20(5):1630-3. PubMed ID: 20138760 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and anticancer effects of some novel pyrazolo[3,4-d]pyrimidine derivatives by generating reactive oxygen species in human breast adenocarcinoma cells. Rashad AE; Mahmoud AE; Ali MM Eur J Med Chem; 2011 Apr; 46(4):1019-26. PubMed ID: 21315495 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and anti-tumor activities of some new pyridines and pyrazolo[1,5-a]pyrimidines. Ahmed OM; Mohamed MA; Ahmed RR; Ahmed SA Eur J Med Chem; 2009 Sep; 44(9):3519-23. PubMed ID: 19398146 [TBL] [Abstract][Full Text] [Related]
30. Novel thiophene derivatives with sulfonamide, isoxazole, benzothiazole, quinoline and anthracene moieties as potential anticancer agents. Ghorab MM; Bashandy MS; Alsaid MS Acta Pharm; 2014 Dec; 64(4):419-31. PubMed ID: 25531783 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and anti-tumor activities of novel pyrazolo[1,5-a]pyrimidines. Li J; Zhao YF; Zhao XL; Yuan XY; Gong P Arch Pharm (Weinheim); 2006 Nov; 339(11):593-7. PubMed ID: 17036367 [TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of 2,4-diamino-6-(arylaminomethyl)pyrido[2,3-d]pyrimidines as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase and as antiopportunistic infection and antitumor agents. Gangjee A; Adair OO; Queener SF J Med Chem; 2003 Nov; 46(23):5074-82. PubMed ID: 14584957 [TBL] [Abstract][Full Text] [Related]
34. Rational design, synthesis, and biological evaluation of bis(pyrimido[5,6,1-de]acridines) and bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as new anticancer agents. Antonini I; Polucci P; Magnano A; Sparapani S; Martelli S J Med Chem; 2004 Oct; 47(21):5244-50. PubMed ID: 15456268 [TBL] [Abstract][Full Text] [Related]
35. Single step synthesis of new fused pyrimidine derivatives and their evaluation as potent Aurora-A kinase inhibitors. Shaaban MR; Saleh TS; Mayhoub AS; Farag AM Eur J Med Chem; 2011 Sep; 46(9):3690-5. PubMed ID: 21664013 [TBL] [Abstract][Full Text] [Related]
36. New annelated thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines, with potent anticancer activity, designed through VLAK protocol. Lauria A; Abbate I; Patella C; Martorana A; Dattolo G; Almerico AM Eur J Med Chem; 2013 Apr; 62():416-24. PubMed ID: 23395722 [TBL] [Abstract][Full Text] [Related]
37. 2-Thienyl-4-furyl-6-aryl pyridine derivatives: synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study. Thapa P; Karki R; Thapa U; Jahng Y; Jung MJ; Nam JM; Na Y; Kwon Y; Lee ES Bioorg Med Chem; 2010 Jan; 18(1):377-86. PubMed ID: 19939682 [TBL] [Abstract][Full Text] [Related]
38. Synthesis of pyrrolo[2,3-d]pyrimidine derivatives and their antiproliferative activity against melanoma cell line. Jung MH; Kim H; Choi WK; El-Gamal MI; Park JH; Yoo KH; Sim TB; Lee SH; Baek D; Hah JM; Cho JH; Oh CH Bioorg Med Chem Lett; 2009 Dec; 19(23):6538-43. PubMed ID: 19857963 [TBL] [Abstract][Full Text] [Related]
39. Synthesis of thiophene and N-substituted thieno[3,2-d] pyrimidine derivatives as potent antitumor and antibacterial agents. Hafez HN; Alsalamah SA; El-Gazzar ABA Acta Pharm; 2017 Sep; 67(3):275-292. PubMed ID: 28858838 [TBL] [Abstract][Full Text] [Related]
40. Synthesis, anticancer activity and radiosensitizing evaluation of some new 2-pyridone derivatives. El-Said MS; El-Gazzar MG; Al-Dosari MS; Ghorab MM Arzneimittelforschung; 2012 Mar; 62(3):149-56. PubMed ID: 22270843 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]